Investors represent an important avenue for Integrated Sensing Systems, Inc. (ISS) to reach a broader set of patients with our wireless implantable sensing monitoring technology. Through our existing collaborations and business development efforts, we aim to:

  • Maximize the commercial value of our existing Wireless Hemodynamic Implantable Monitoring devices through select clinical development and commercial alliances that broaden patient reach.
  • Leverage the broad potential of our proprietary MEMS based wireless implantable sensing monitoring technology technologies through research and development collaborations and out-licensing arrangements.
  • Build our pipeline and product portfolio in our primary area of focus, Congestive Heart Failure market through in-licensing, acquisition and co-development opportunities.

Investment opportunity is available to continue the successful release of cardiac health monitoring product for both adults and pediatric patients. The Medical Business Unit is in development with a  breakthrough technology for the cardiac health industry. For more information Contact Us and we will forward an investors presentation with more details.